Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Tandem Diabetes Care’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001438133-26-000125
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Investing Activities | ||
| Purchases of short-term investments | (260,512) | (26,496) |
| Proceeds from maturities and redemptions of short-term investments | 69,473 | 146,447 |
| Purchases of property and equipment | (10,318) | (9,171) |
| Acquisition of in-process research and development | — | (43,464) |
| Purchases of equity investments, strategic investments, and intangible assets | (81,427) | — |
| Net cash provided by (used in) investing activities | (282,784) | 67,316 |
| Financing Activities |
Item 1. Financial Statements.
FAQ
- What is Tandem Diabetes Care's capex?
- Tandem Diabetes Care (TNDM) reported capex of $4.05M in Q2 2026.
- How has Tandem Diabetes Care's capex changed year-over-year?
- Tandem Diabetes Care's capex decreased by 34.7% year-over-year, from $6.21M to $4.05M.
- What is the long-term trend for Tandem Diabetes Care's capex?
- Over 4 years (2021 to 2025), Tandem Diabetes Care's capex has grown at a 8.9% compound annual growth rate (CAGR), from $14.18M to $19.95M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Tandem Diabetes Care's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude